Acrivon Therapeutics (NASDAQ:ACRV) Now Covered by Analysts at Piper Sandler
Analysts at Piper Sandler assumed coverage on shares of Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) in a research report issued on Monday, MarketBeat reports. The firm set an “overweight” rating and a $6.00 price target on the stock. Piper Sandler’s target price would indicate a potential upside of 352.83% from the company’s current price. […]
Analysts at Piper Sandler assumed coverage on shares of Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) in a research report issued on Monday, MarketBeat reports. The firm set an “overweight” rating and a $6.00 price target on the stock. Piper Sandler’s target price would indicate a potential upside of 352.83% from the company’s current price. […]
